Menu

Universal Technical Institute, Inc. (UTI)

$25.94
+1.10 (4.43%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Market Cap

$1.4B

Enterprise Value

$1.5B

P/E Ratio

22.4

Div Yield

0.00%

Rev Growth YoY

+14.0%

Rev 3Y CAGR

+25.9%

Earnings YoY

+50.0%

Earnings 3Y CAGR

+34.6%

Company Profile

At a glance

UTI has entered Phase 2 of its North Star strategy, a deliberate investment period that will see approximately $40 million in growth spending during fiscal 2026, temporarily pressuring reported EBITDA to $114-119 million while building a foundation for margin expansion to approach 20% by 2029.

The regulatory environment has shifted decisively in UTI's favor: Concorde's growth restrictions were lifted a full year ahead of schedule, the One Big Beautiful Bill Act (OBBBA) is making short-course programs Pell-eligible, and the current administration has demonstrated strong support for technical education, accelerating approval processes.

Demand fundamentals are robust across both segments, with the UTI division growing average full-time active students by 8% and Concorde expanding by 14.5%, driven by a national skilled labor shortage that requires 111,000 new automotive technicians and 1.29 million healthcare support workers annually through 2034.

Price Chart

Loading chart...